WO2006128583A1 - Cosmetic preparations containing aqueous anise fruit extract and one or several acrylamide-methyl-propyl-sulfonic acid polymers - Google Patents

Abstract

The invention relates to cosmetic preparations containing (i) an aqueous anise fruit extract and (ii) one or several acrylamide-methyl-propyl-sulfonic acid polymers.

Description

 Beiersdorf Aktiengesellschaft

description

Cosmetic preparations containing an aqueous aniseed extract and one or more acrylamidomethylpropylsulfonic acid polymers

The present invention relates to cosmetic preparations containing an aqueous aniseed fruit extract and Acrylamidomethylpropylsulfonsäure polymer and their use in the field of cosmetic and pharmaceutical dermatology.

The outermost layer of the epidermis, the stratum corneum (horny layer), ^'is an important barrier layer is of particular importance, inter alia, for protection against environmental influences and dehydration. The horny layer is constantly worn in contact with the environment and must therefore be renewed continuously.

A skin model widely used today in the art understands the stratum corneum as a two-component system, similar to a brick wall (brick-mortar model). In this model, the corneocytes (homocells) correspond to the bricks, the complex composite lipid membrane in the intercellular spaces corresponds to the mortar.

In addition to their barrier effect against external chemical and physical influences, the epidermal lipids also contribute to the cohesion of the horny layer and have an influence on the skin smoothness. In contrast to the sebaceous gland lipids, which do not form a closed film on the skin, the epidermal lipids are distributed over the entire horny layer.

The extremely complex interaction of the moisture-binding substances and the lipids of the upper skin layers is very important for the regulation of skin moisture. Therefore, cosmetics usually contain, in addition to balanced lipid mixtures and water, water-binding substances. These include u.a. Polyols such as glycerol, sorbitol and xylitol, ethoxylated polyols and hydrolyzed proteins. Further applications find the substances contained in the natural moisturizing factor (so-called Natural Moisturizing Factor = NMF), such as.

Wi / 2005 / 02221.doc Urea, carbohydrates (eg glucose) and amino acids (eg serine). These substances are therefore of particular importance for the care performance of a cosmetic product, in particular because of their relatively good skin and mucous membrane compatibility.

Unresolved, however, was the problem that in the incorporation of aqueous Anisfruchxtrakten in O / W emulsions and hydrodispersions due to the natural salt content of the extracts, the emulsion stability and viscosity of the emulsions was greatly reduced. This problem could not be adequately resolved with the acrylate polymers (carbomers) otherwise used in cosmetic emulsions.

It was surprising and unpredictable after all that cosmetic preparations containing

(i) an aqueous aniseed extract and

(ii) one or more acrylamidomethylpropyl sulfonic acid polymers overcome the disadvantages of the prior art.

It was further surprising that the use of one or more acrylamido methylpropylsulfonsäure polymers to increase the stability of cosmetic preparations containing an aqueous Anisfruchxtrakt the disadvantages of the prior art would remedy.

Furthermore, it has not been foreseen for the skilled person that the active ingredient combinations according to the invention or cosmetic or dermatological preparations containing them better than moisturizing agent will better protect against dehydration by emulsifiers and coemulsifiers better improve the barrier performance of the skin better protects the skin from exogenous noxious substances better against the symptoms of sensitive skin better protects the skin roughness reduces better against aging of the skin act as the active ingredients, drug combinations and preparations of the prior art. It is particularly advantageous according to the invention, an aqueous fruit extract from anise (Pim pinella anis fruit extract), which is rich in inorganic minerals such as sodium and magnesium ions, especially potassium ions and with butylene glycol 0.36% and parabens 0.14% is conserved and obtainable by enzymatic hydrolysis in water of solubilized aniseed fruit, wherein the ratio of raw material to extract is about ^Λ A and is available under the trade name Bioxilift from SILAB, (Brive Cedex, France)

Cosmetic or dermatological preparations according to the present invention advantageously contain 0.05 to 5% by weight, in particular 0.1 to 3% by weight, based on the total weight of the preparations, of one or more polymer thickeners from the group of the acrylamidomethylpropylsulfonic acid polymers (US Pat. AMPS polymers)

The polymer thickeners according to the invention are water-soluble or water-swellable and preparable

- By radical polymerization of 2-acrylamido-2-methylpropanesulfonic acid by radical copolymerization of 2-acrylamido-2-methylpropanesulfonic acid and. one or more macromonomers containing an end group capable of polymerization, a hydrophilic part based on polyalkylene oxides and a hydrophobic part containing hydrogen or a saturated or unsaturated, linear or branched, aliphatic, cycloaliphatic or aromatic (C ₁ -C ₃₀ ) - Hydrocarbon radical comprises, and / or

one or more olefinically unsaturated comonomers containing oxygen, nitrogen, sulfur, phosphorus, chlorine and / or fluorine produced.

The macromonomers A) are preferably those of the formula

R ¹ -Y- (R ² -O) _X -R ³ , wherein R ^{1 is} a vinyl, allyl, acrylic or methacrylic radical; R ^{2 is} (C ₂ -C ₄ ) alkylene; x is an integer between 1 and 500; Y is oxygen, sulfur, PH or NH and R ^{3 is} hydrogen or a saturated or unsaturated, linear or branched, aliphatic, cycloaliphatic or aromatic (C ₁ to C ₃₀ ) hydrocarbon radical.

R1 is particularly preferably an acrylic or methacrylic radical. R ² is particularly important zugt for an ethylene or propylene radical. More preferably, x is a number between 3 and 50, more preferably a number between 7 and 30. R3 is preferably aliphatic or cycloaliphatic hydrocarbons, which may be saturated or unsaturated. R ³ particularly preferably represents a (C ₆ to C ₂₂ ) hydrocarbon radical, particularly preferably a (C ₁₂ to C ₁₈ ) hydrocarbon radical.

The monomer distribution of the macromonomers A) and / or comonomers B), and 2-acrylamido-2-methylpropanesulfonic acid in the polymers can be, for example, alternating, blocky (also multiblock) or random (also gradient). The polymers generally have a number average molecular weight of from 1000 to 20,000,000 g / mol, preferably from 20,000 to 5,000,000, particularly preferably from 100,000 to 1,500,000 g / mol.

In a preferred embodiment, the polymers of the invention are crosslinked, d. H. they contain at least one crosslinker having at least two double bonds, which is polymerized into the polymer. Suitable crosslinkers are in particular Methylenbisacryl- and - methacrylamide, esters of unsaturated mono- or polycarboxylic acids with polyols, eg. As diacrylates or triacrylates, such as. For example, butanediol and ethylene glycol diacrylate or methacrylate and Trimethy- lolpropantriacrylat, allyl compounds such. As allyl (meth) acrylate, triallyl cyanurate, maleic acid diallyl esters, polyallyl esters, tetraallyloxyethane, triallylamine, tetraallylethylenediamine, allyl esters of phosphoric acid and / or vinylphosphonic acid derivatives.

The AMPS polymers may be commercially available as 100% active ingredient or as inverse thickener. Examples: crosslinked AMPS copolymers, powder form:

Aristoflex AVC (ammonium acryloyldimethyltaurate / VP Copolymer, Clariant)

Aristoflex HMB (ammonium acryloyldimethyltaurate / beheneth-25 methacrylate copolymer, Clariant)

Crosslinked AMPS copolymers, inverse thickeners:

Simulgel NS (Seppic): Hydroxyethyl acrylate / sodium acryloyl dimethyl taurate

Copolymer / squalane / polysorbate Polymers advantageous according to the invention are described, for example, in DE 100 29 462 A1.

According to preferred Acrylamidomethylpropylsulfonsäure polymer is the Ammoniu- macryloyldimethyltaurat / VP copolymer.

Cosmetic or dermatological preparations for the purposes of the present invention advantageously contain 0.05 to 5% by weight, in particular 0.1 to 3% by weight, based on the total weight of the preparations, of one or more acrylamidomethylpropylsulfonic acid polymers.

According to the invention particularly advantageous AMPS polymers, the ammonium acryloyldimethyltaurate / vinylpyrrolidone copolymers have the empirical formula [C ₇ H ₁₆ N ₂ SO ₄ J _n [C ₆ H ₉ NO]., Corresponding to a statistical structure as follows

Preferred species for the purposes of the present invention are filed in the Chemical Abstracts under the filing numbers 58374-69-9, 13162-05-5 and 88-12-0 and available under the trade name Aristoflex® AVC from Clariant GmbH.

It is advantageous according to the invention to select the molar ratio of an aqueous aniseed extract to AMPS polymer in the range from 100: 1 to 1: 100, preferably 50: 1 to 1:50, particularly preferably 20: 1 to 1:20. According to the use according to the invention, the preparations are particularly advantageously characterized in that the one aqueous aniseed extract in concentrations of 0.01 to 10.00 wt .-%, preferably 0.05 to 5.00 wt .-%, particularly preferably 0.1 3.00% by weight, based in each case on the total weight of the composition.

Cosmetic preparations in which the aqueous aniseed extract is present in concentrations of 0.01-10.00% by weight, preferably 0.05-5.00% by weight, more preferably 0.1-3.00% by weight, each based on the total weight of the composition, is present, are also advantageous according to the invention.

It is likewise advantageous to add conventional antioxidants to the preparations for the purposes of the present invention. According to the invention, all antioxidants which are suitable or customary for cosmetic and / or dermatological applications can be used as favorable antioxidants.

Advantageously, the antioxidants are selected from the group consisting of amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, peptides such as D, L-camosine, D-carnosine, L-carnosine and their derivatives (eg anserine), carotenoids ( eg α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (eg dihydrolipoic acid), thiols (eg thioredoxin, glutathione, cysteine, cystine, cystamine) and their salts,, furthermore (metal ) Chelating agents (eg g-hydroxyfatty acids, phytic acid, lactoferrin), α-hydroxy acids (eg citric acid, lactic acid, malic acid), bile acid, bile extracts, bilirubin, biliverdin, EDTA, iminodisuccinate, unsaturated fatty acids and their derivatives (eg α-linolenic acid , Linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and their derivatives (in particular ubiquinone Q10), vitamin C and derivatives (eg ascorbyl palmitate, Na ascorbyl phosphate), tocopherols and derivatives (eg Vit amine E-acetate), vitamin A and derivatives (vitamin A palmitate), rutinic acid and its derivatives, plant polyphenols with a logP of 1-3, quercetin, isoflavones, genistein, genistin, daidzein, α-glycosylrutin, ferrous lauric acid, furfurylidene glucitol, carnosine, butylhydroxytoluene, butylated hydroxyanisole, mannose and their derivatives. The amount of antioxidants (one or more compounds) in the preparations is preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20% by weight, in particular from 1 to 10% by weight, based on the total weight of the preparation ,

The cosmetic preparations according to the invention may contain cosmetic aids as are commonly used in such preparations, e.g. Preservatives, bactericides, antioxidants, UV filters, perfumes, antifoaming agents, dyes, pigments which have a coloring effect, thickeners, surface-active substances, emulsifiers, emollients, moisturizing and / or moisturizing substances, fats, oils, waxes or other common ingredients of a cosmetic formulation such as alcohols, polyols, polymers, foam stabilizers, electrolytes, organic solvents or silicone derivatives.

Accordingly, the preparations according to the present invention preferably contain at least one further UV-A, UV-B and / or broad-spectrum filter substance. The formulations may, although not necessary, optionally also contain one or more organic and / or inorganic pigments as UV filter substances, which may be present in the water and / or the oil phase.

The preparations according to the invention may also advantageously be in the form of so-called oil-free cosmetic or dermatological emulsions which contain a water phase and at least one UV filter substance which is liquid at room temperature as further phase.

Particularly advantageous UV filter substances which are liquid at room temperature in the context of the present invention are homomenthylsalicylate (INCI: homosalates), 2-ethylhexyl-2-cyano-3,3-diphenylacrylate (INCI: octocrylene), 2-ethylhexyl-2-hydroxybenzoate (2 Ethylhexyl salicylate, octyl salicylate, INCI: octyl salicylate) and esters of cinnamic acid, preferably 4-methoxycinnamic acid (2-ethylhexyl) ester (2-ethylhexyl-4-methoxycinnamate, INCI: octyl methoxycinnamate) and isopentyl 4-methoxycinnamate (isopentyl-4 methoxycinnamate, INCI: isoamyl p-methoxycinnamate).

Preferred inorganic pigments are metal oxides and / or other sparingly water-soluble or insoluble metal compounds, in particular oxides of titanium (TiO ₂ ), zinc (ZnO), Iron (eg Fe ₂ O ₃ ), zirconium (ZrO ₂ ), silicon (SiO ₂ ), manganese (eg MnO), aluminum (Al ₂ O ₃ ), cerium (eg Ce ₂ O ₃ ), mixed oxides of the corresponding metals and mixtures of such oxides and the sulfate of barium (BaSO ₄ ).

For the purposes of the present invention, the pigments can also be used advantageously in the form of commercially available oily or aqueous predispersions. Advantageously, dispersants and / or solubilizers can be added to these predispersions.

According to the invention, the pigments can advantageously be treated superficially, it being intended, for example, to form or retain a hydrophilic, amphiphilic or hydrophobic character. This surface treatment may consist in providing the pigments with a thin hydrophilic and / or hydrophobic inorganic and / or organic layer by processes known per se. The various surface coatings may also contain water for the purposes of the present invention.

Inorganic surface coatings for the purposes of the present invention may consist of aluminum oxide (Al ₂ O ₃ ), aluminum hydroxide Al (OH) ₃ , or aluminum oxide hydrate (also: alumina, CAS No .: 1333-84-2), sodium hexametaphosphate (NaPO ₃ ). ₆ , sodium metaphosphate (NaPO ₃ ) _n , silicon dioxide (SiO ₂ ) (also: silica, CAS No .: 7631-86-9), or iron oxide (Fe ₂ O ₃ ). These inorganic surface coatings may be present alone, in combination and / or in combination with organic coating materials.

Organic surface coatings for the purposes of the present invention may consist of vegetable or animal aluminum stearate, vegetable or animal stearic acid, lauric acid, dimethylpolysiloxane (also: dimethicone), methylpolysiloxane (methicone), simethicone (a mixture of dimethylpolysiloxane with an average chain length of 200 to 350 Dimethylsiloxane units and silica gel) or alginic acid. These organic surface coatings may be present alone, in combination and / or in combination with inorganic coating materials.

Zinc oxide particles which are suitable according to the invention and predispersions of zinc oxide particles are obtainable from the following companies under the following commercial names:

Suitable titanium dioxide particles and predispersions of titanium dioxide particles are available from the following companies under the following trade names:

Advantageous UV-A filter substances for the purposes of the present invention are dibenzoyl methane derivatives, in particular the 4- (tert-butyl) -4'-methoxydibenzoylmethane (CAS No. 70356-09-1), which is sold by Givaudan under the trade name Parsol ^® is sold in 1789 and by Merck under the trade name Eusolex® 9020th

Advantageous further UV filter substances in the context of the present invention are sulfonated, water-soluble UV filters, such as. B .:

Phenylene-1,4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and its salts, especially the corresponding sodium, potassium or triethanolammonium salts, especially the phenylene-1, 4- bis- (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid bis-sodium salt with the INCI name bisimidazylate (CAS No .: 180898-37-7), which is available, for example, under the trade name Neo Heliopan AP available from Haarmann &Reimer;

Salts of 2-phenylbenzimidazole-5-sulfonic acid, such as its sodium, potassium or triethanolammonium salt, and also the sulfonic acid itself with the INCI name phenyl- benzimidazole sulfonic acid (CAS No. 27503-81-7), which is available, for example, under the trade name Eusolex 232 from Merck or from Neo Heliopan Hydro from Haarmann &Reimer;

1, 4-di (2-oxo-10-sulfo-3-bornylidenemethyl) benzene (also: 3,3 '- (1,4-phenylenedimethylene) bis (7,7-dimethyl-2-oxo) bicyclo- [2.2.1] hept-1-ylmethane sulfonic acid) and its salts (especially the corresponding 10-sulfato compounds, in particular the corresponding sodium, potassium or triethanolammonium salt), which is also known as benzene-1, 4- Benzo-1,4-di (2-oxo-3-bomylidenemethyl-10-sulfonic acid) has the INCI name Terephtalidene Dicampher sulfonic acid (CAS. No .: 90457-82-2) and is available, for example, under the trade name Mexoryl SX from Chimex;

Sulfonic acid derivatives of 3-Benzylidencamphers, such as. B. 4- (2-oxo-3-bomylidenemethyl) - benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidenemethyl) sulfonic acid and salts thereof.

Advantageous UV filter substances for the purposes of the present invention are also so-called broadband filters, i. Filter substances that absorb both UV-A and UV-B radiation.

Advantageous broadband filters or UV-B filter substances are, for example, triazine derivatives, such as. B.

2,4-bis - {[4- (2-ethyl-hexyloxy) -2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1, 3,5-triazine (INCI: aniso triazine), which is available under the trade name Tinosorb® S is available from CIBA-Chemikalien GmbH;

Diethylhexylbutylamidotriazone (INCI: diethylhexylbutamidotriazone), available under the trade designation UVASORB HEB from Sigma 3V;

4,4 ', ^ - (1 _l 3,5-triazine-2,4,6-triyltriimino) tris-benzoic acid tris (2-ethylhexyl ester), also: 2,4,6-tris [anilino- (p-carbo-2-ethyl-1-hexyloxy)] - 1, 3,5-triazine (INCI: ethylhexyl triazone), which is marketed by BASF Aktiengesellschaft under the trade name UVINUL® T 150.

An advantageous broadband filter for the purposes of the present invention is also the 2,2'-methylenebis (6- (2H-benzotriazol-2-yl) -4- (1,1,3,3-tetramethylbutyl) phenol), which is available under the trade name Tinosorb® M from CIBA-Chemikalien GmbH. Advantageous broadband filter for the purposes of the present invention is also the 2- (2H-benzotriazole) -ylM-methyl-e - ^ -methyl-S-fi .SSS-tetramethyl-i- ^ trimethylsilyOoxyJdisiloxanyOpropyl] - phenol (CAS no. : 155633-54-8) with the INCI name Drometrizole Trisiloxane, which is available under the trade name Mexoryl® XL from Chimex.

The other UV filter substances can be oil-soluble or water-soluble.

Advantageous oil-soluble UV-B and / or broadband filter substances in the sense of the present invention

Invention are z. B .:

■ 3-benzylidene camphor derivatives, preferably 3- (4-methylbenzylidene) camphor, 3-benzylidene camphor;

^■ cinnamic acid derivatives, preferably 2-Ethylhexylmethoxycinnamate (CAS No .: 5466-77-3), which is available under the trade name Parsol MCX from Givaudan.

■ 4-aminobenzoic acid derivatives, preferably (2-ethylhexyl) -4- (dimethylamino) benzoate, 4- (dimethylamino) benzoic acid amyl ester;

■ Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4-methylbenzophenone, 2,2-dihydroxy-4-methoxybenzophenone

■ as well as UV-bound polymers.

■ 3- (4- (2,2-bis ethoxycarbonylvinyl) phenoxy) propenyl) methoxysiloxane / dimethylsiloxane copolymer, which is available, for example, under the trade name Parsol® SLX from Hoffmann La Roche.

Advantageous water-soluble filter substances are z. B.: Sulfonic acid derivatives of 3-Benzylidencamphers, such as. B. 4- (2-oxo-3-bomylidenemethyl) benzenesulfonic acid, 2-methyl-5- (2-oxo-3-bomylidenemethyl) sulfonic acid and salts thereof.

A further light protection filter substance according to the invention to be used advantageously is ethylhexyl-2-cyano-3,3-diphenylacrylate, obtainable (octocrylene) from BASF under the name Uvinul ^® N 539th

Particularly advantageous preparations in the context of the present invention, which are distinguished by a high or very high UV-A and / or UV-B protection, preferably contain, in addition to the filter substance (s) according to the invention further UV-A and /or Broadband filter, in particular Dibenzoylmethanderivate [for example, the 4- (tert-butyl) -4'-methoxydibenzoylmethan], phenylene-1 _I 4-bis (2-benzimidazyl) -3,3'-5,5'-tetrasulfonic acid and / or their salts, the 1,4-di (2-oxo-10-sulfo-3-bomylidenemethyl) benzene and / or its salts and / or the 2,4-bis - [[4- (2-ethyl-hexyloxy) 2-hydroxy] -phenyl} -6- (4-methoxyphenyl) -1,3,5-triazine, each individually or in any combination with one another.

The list of said UV filters which can be used in the context of the present invention is of course not intended to be limiting.

Advantageously, the preparations of the invention contain the substances which absorb UV radiation in the UV-A and / or UV-B range, in a total amount of z. B. 0.1 wt .-% to 30 wt .-%, preferably 0.5 to 20 wt .-%, in particular 1, 0 to 15.0 wt .-%, each based on the total weight of the preparations to cosmetic To provide preparations that protect the hair or the skin from the entire range of ultraviolet radiation.

If the cosmetic or dermatological preparation is a solution or lotion, the solvents used may be: water or aqueous solutions;

Oils such as triglycerides of capric or caprylic acid, fatty acid ethers such as dicaprylyl ether, carbonic acid esters such as dicaprylyl carbonate, and vegetable triglycerides such as sunflower oil; Octyldodecanol, cyclomethicone, dimethicone

Fats, waxes and other natural and synthetic fats, preferably esters of fatty acids with lower C-number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols with alkanoic acids of low C number or with fatty acids;

Alcohols, diols or polyols of low C number, and also their ethers, preferably ethanol, isopropanol, propylene glycol, glycerol, ethylene glycol, ethylene glycol monoethyl or monobutyl ether, propylene glycol monomethyl, monoethyl or monobutyl ether, diethylene glycol monomethyl or monoethyl ether, ethylhexyl glycerol, Methylpropanediol and analog products.

In particular, mixtures of the abovementioned solvents are used. For alcoholic solvents, water can be another ingredient. Preferred O / W emulsifiers are glyceryl stearate citrate, polyglyceryl-3-methyl glucose distearate, cetearyl glucosides, PEG-40 stearate, PEG-100 stearate, stearic acid, ceteareth-20, steareth-20, steareth-21 and glyceryl stearate.

Cosmetic preparations in the sense of the present invention can also be present as gels which, in addition to an effective content of the active ingredient according to the invention and solvents used for this purpose, preferably water, additionally contain additional organic and / or inorganic thickeners. Furthermore, these thickeners are part of cosmetic emulsions.

Advantageous additional thickeners for such preparations are, for example, copolymers of C ₁₀ . ₃₀ alkyl acrylates and one or more monomers of acrylic acid, methacrylic acid or their esters. The INCI name for such compounds is "acrylates / C 10-30 alkyl acrylate crosspolymer." Particularly advantageous are the Pemulen® types TR 1, TR 2 and TRZ from Goodrich (Noveon).

Carbopols are also advantageous additional gelling agents for such preparations. Carbopols are polymers of acrylic acid, especially acrylate-alkyl acrylate copolymers. Examples of advantageous carbopols are types 980, 981, 984 1342, 1382, 2984 and 5984. Likewise ETD types 2001, 2020, 2050 and Carbopol Ultrez 10, PVM / MA Decadiene Crosspolymer (trade name Stabileze 06), polyglyceryl methacrylate and polyacrylamide. Further advantageous gelling agents for such preparations are xanthan gum, polyvinylpyrrolidone, cellulose derivatives, in particular cellulose ethers such as, for example, hydroxypropylmethylcellulose, starch and starch derivatives, hyaluronic acid locust bean gum, silicon dioxide and aluminum silicates.

The thickening agent is present in the gel, dispersion or emulsion e.g. in an amount of between 0.01 and 5% by weight, preferably between 0.1 and 2% by weight.

Following are advantageous embodiments of the present invention.

Claims

claims: Cosmetic preparations containing (i) an aqueous aniseed extract and (ii) one or more acrylamidomethylpropyl sulfonic acid polymers. 2. Preparations according to Claim 1, in which the ratio of the aqueous aniseed extract to one or more acrylamidomethylpropylsulfonic acid polymer is in the range from 100: 1 to 1: 100, preferably 50: 1 to 1:50, particularly preferably 20: 1 to 1: 20 is selected. 3. Cosmetic preparations according to claim 3, in which the aqueous aniseed extract in concentrations of 0.01 to 10.00 wt .-%, preferably 0.05 to 5.00 wt .-%, particularly preferably 0.1 to 3.00 Wt .-%, each based on the total weight of the composition is present. 4. Cosmetic preparations according to claim 3, in which the or the acrylamido methylpropylsulfonsäure polymers in concentrations of 0.01 to 10.00 wt .-%, preferably 0.05 to 5.00 wt .-%, particularly preferably 0, 1 - 3.00 wt .-%, in each case based on the total weight of the composition, is present or present